reglab/housing_qa huggingface dataset:
16 DE Code § 3001L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3001L. Short title.

§ 3001L. Short title. This chapter shall be known and may be cited as the “Concussion Protection in Youth Athletic Activities Act.” 80 Del. Laws, c. 409, §  1;
16 DE Code § 3002L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3002L. Purpose.

§ 3002L. Purpose. The purposes of this chapter are to protect minors participating in athletic activities who manifest symptoms of concussion, increase recognition of the symptoms of concussion through training and education, and establish standards for return to play. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3003L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3003L. Definitions.

§ 3003L. Definitions. For purposes of this chapter:  (1) “Athlete” means a person who engages in athletic activity who is less than 18 years of age. (2) “Athletic activity” means participation of an athlete in an athletic program or event with on-site coach oversight occurring in the State, including practice or competition, which is:  a. Organized or primarily sponsored by a public, for-profit, or nonprofit organization, including a club, league, or association; b. A significant concussion risk activity; c. Not regulated by the Delaware Interscholastic Athletic Association pursuant to Chapter 3 of Title 14; d. Not part of a school-sponsored field day, supervised recess, gym or physical education class; and e. Not part of a college or university-sponsored program or event involving its students. (3) “Concussion” means a traumatic injury to the brain causing a change in a person's mental status at the time of injury, such as feeling dazed, disoriented, or confused, which may or may not involve a loss of consciousness, resulting from:  a. A fall; b. A blow or jolt to the head or body; c. The shaking or spinning of the head or body; or d. The acceleration or deceleration of the head. (4) “Council” means the State Council for Persons with Disabilities. (5) “Division” means the Division of Public Health. (6) “Health-care provider” means a licensed physician (Doctor of Medicine or Doctor of Osteopathic Medicine) or such other licensed health-care professional as may be designated by the Division, in consultation with the Council, through regulation. (7) “Official” means an umpire, referee, or other official who is actively engaged in the officiating of a significant concussion-risk activity. (8) “Significant concussion risk activity” means football, rugby, soccer, basketball, lacrosse, field hockey, ice hockey, wrestling, volleyball, martial arts, combative sports, gymnastics, baseball, softball, cheerleading, and such other athletic activities as may be identified by the Division through regulation developed in consultation with the Council as statistically correlated with a significant risk of concussion.80 Del. Laws, c. 409, §  1;
16 DE Code § 3004L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3004L. Concussion protection.

§ 3004L. Concussion protection. (a) An athlete who is suspected of sustaining a concussion in an athletic activity shall be immediately removed from physical participation in the athletic activity and shall not return to that athletic activity on the same day. (b) An athlete who has been removed from an athletic activity may not return to physical participation in an athletic activity until evaluated by a health-care provider and the athlete receives written clearance to return to physical participation in an athletic activity from the evaluating health-care provider. (c) The coach or official responsible for an athlete's removal shall ensure that prompt notice is provided to the athlete's parent or guardian of both the removal and medical clearance requirement. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3005L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3005L. Materials development and distribution.

§ 3005L. Materials development and distribution. Before an athlete may participate in an athletic activity, the organizing entity shall provide a concussion information sheet published by the Council to the athlete and the parent or guardian of the athlete. The athlete and the parent or guardian of the athlete shall sign a statement acknowledging receipt of the information sheet and return it to the organizing entity before the athlete shall be allowed to participate in the athletic activity. For recurrent or on-going athletic activity, the provision of the information sheet and return of the signed acknowledgment shall be completed annually. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3006L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3006L. Coach and official training.

§ 3006L. Coach and official training. Each on-site official and coach responsible for selection of participants for an athletic activity shall complete initial and periodic concussion training consistent with a schedule and content standards published by the Council. The schedule and content standards shall not exceed any coach or official concussion training requirements adopted by the Delaware Interscholastic Athletic Association and shall include the opportunity to complete verifiable training online. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3007L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3007L. Regulations.

§ 3007L. Regulations. The Division, in consultation with the Council and other stakeholders, may promulgate regulations to implement § 3003L(6) and (8) of this title. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3008L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3008L. Exclusion of application of chapter.

§ 3008L. Exclusion of application of chapter. The requirements of §§ 3005L and 3006L of the title shall not apply to coaches, athletes, officials, parents and guardians of visiting teams or groups of participants from outside the State. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3009L. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30L. Concussion Protection in Youth Athletic Activities Act|§ 3009L. Annual report.

§ 3009L. Annual report. The Council may include in its annual report information concerning implementation of this chapter obtained through surveys, the Internet, and other sources. 80 Del. Laws, c. 409, §  1;
16 DE Code § 3001M. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30M. Lead Paint on Outdoor Structures|§ 3001M. Purpose.

§ 3001M. Purpose. The purpose of this chapter is to reduce risks to public health and welfare by banning the use of lead paints on outdoor structures in Delaware.  81 Del. Laws, c. 396, § 1;
16 DE Code § 3002M. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30M. Lead Paint on Outdoor Structures|§ 3002M. Definitions.

§ 3002M. Definitions. For purposes of this chapter, the following terms shall have the meanings defined in this section:  (1) “Lead paint” means paint containing lead or lead compounds and in which the lead is in excess of 90 parts per million (ppm) by weight of the total nonvolatile content of the paint or the weight of the dried paint film.  (2) “Outdoor structure” means any manmade permanent or semi-permanent structure or assemblage of parts, some or all of the surface of which is exposed to rain, snow, sunlight, humidity, or other outdoor forces of nature. Outdoor structures include bridges, water towers, pipes, playground equipment, highways, parking lots, guard rails, and poles or towers used in the transmission of telephone, internet, or electric power. (3) “Paint” means varnishes, lacquers, enamels, glazes, primers, or other surface-coating materials used for any purpose; and is typically a mixture of resins, pigments, fillers, solvents, and other additives that constitute a finished product. (4) “Person” means an individual, partnership, corporation, association, nonprofit, or governmental entity. 81 Del. Laws, c. 396, § 1;
16 DE Code § 3003M. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30M. Lead Paint on Outdoor Structures|§ 3003M. Prohibition on use of lead paints on outdoor structures [See differing delayed effective dates for this section in §  3005M of this title].

§ 3003M. Prohibition on use of lead paints on outdoor structures [See differing delayed effective dates for this section in §  3005M of this title]. The use by any person of lead paints on outdoor structures, whether applied to new outdoor structures or already existing outdoor structures, shall be prohibited after the effective dates in this chapter. 81 Del. Laws, c. 396, § 1;
16 DE Code § 3004M. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30M. Lead Paint on Outdoor Structures|§ 3004M. Penalties and enforcement.

§ 3004M. Penalties and enforcement. (a) The Secretary of Department of Health and Social Services, or the Director of the Division of Public Health, or their designee shall enforce this chapter.  (b) Whoever violates this chapter or any rule or regulation duly promulgated thereunder, shall be punishable as follows by an administrative penalty imposed of not more than $10,000 per day for each completed violation. Each day of continued violation shall be considered as a separate violation.  81 Del. Laws, c. 396, § 1;
16 DE Code § 3005M. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30M. Lead Paint on Outdoor Structures|§ 3005M. Effective date.

§ 3005M. Effective date. The prohibition in this chapter for any new use or application of lead-based paints, pigments, and coatings shall become effective January 1, 2020. The prohibition in this chapter for any use or application of lead-based paints, pigments, and coatings that occurred prior to January 1, 2020, shall become effective on January 1, 2024.  81 Del. Laws, c. 396, § 1;
16 DE Code § 3001N. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30N. Lyme Disease Information [Expires Aug. 21, 2022].|§ 3001N. Provision of information relating to Lyme disease [Expires Aug. 21, 2022].

§ 3001N. Provision of information relating to Lyme disease [Expires Aug. 21, 2022]. (a) A health-care provider who draws the blood of a patient to perform a laboratory test for Lyme disease shall provide the patient with the following written notice, or a substantially similar notice, at the time the patient's blood is drawn:  “Your health-care provider has ordered a laboratory test for the presence of Lyme disease for you. Current laboratory testing for Lyme disease, like all standard laboratory tests, can result in false negatives and false positives. If you continue to experience unexplained symptoms, you should contact your health-care provider and inquire about the appropriateness of retesting or initial or additional treatment.” (b) Notwithstanding any other law, this section does not create a cause of action or create a standard of care, obligation, or duty that provides a basis for a cause of action. (c) The information required by this section or evidence that a person violated this section is not admissible in a civil, judicial, or administrative proceeding. 82 Del. Laws, c. 210, § 1;
16 DE Code § 3001O. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30O. Dispensing and Dispensing and Administering Injectable Hormonal Contraceptives by Pharmacists.|§ 3001O. Definitions.

§ 3001O. Definitions. For purposes of this chapter:  (1) “Contraceptives” means contraceptive medications approved by the Food and Drug Administration. (2) “Health-care practitioner” means an individual licensed and authorized to write medical orders for an individual under Title 24. (3) “Pharmacist” means an individual licensed under Chapter 25 of Title 24.83 Del. Laws, c. 240, § 1;
16 DE Code § 3002O. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30O. Dispensing and Dispensing and Administering Injectable Hormonal Contraceptives by Pharmacists.|§ 3002O. Dispensing or dispensing and administering contraceptives by pharmacists; standing order.

§ 3002O. Dispensing or dispensing and administering contraceptives by pharmacists; standing order. (a) The Department shall create a written standing order that allows a pharmacist to dispense contraceptives and dispense and administer injectable hormonal contraceptives under the standing order. (b) The standing order under this section must require a pharmacist to comply with the rules and regulations promulgated under this chapter and must include all of the following:  (1) The standard procedures that a pharmacist must use to select the appropriate contraceptive to dispense to a patient or to refer the patient to a health-care practitioner for treatment. (2) The conditions under which a pharmacist may dispense contraceptives. (3) The conditions under which a pharmacist may dispense and administer injectable hormonal contraceptives.83 Del. Laws, c. 240, § 1;
16 DE Code § 3003O. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 30O. Dispensing and Dispensing and Administering Injectable Hormonal Contraceptives by Pharmacists.|§ 3003O. Dispensing or dispensing and administering contraceptives by pharmacists; regulations.

§ 3003O. Dispensing or dispensing and administering contraceptives by pharmacists; regulations. (a) The Department shall promulgate regulations to implement this chapter, in consultation with applicable licensing boards, including the Board of Pharmacy and the Board of Medical Licensure and Discipline, (b) The regulations promulgated under this section must include the length of time a person may receive contraceptives under this chapter without an examination by a health-care practitioner. (c) The regulations promulgated under this section must require a pharmacist to do all of the following:  (1) Complete an approved training program related to dispensing and administering contraceptives under the standing order. (2) Provide a self-screening risk assessment tool that the patient must use prior to the pharmacist dispensing or dispensing and administering the contraceptive. (3) Refer the patient to the patient's health-care practitioner upon dispensing or dispensing and administering the contraceptive for any additional care. (4) Provide the patient with all of the following:  a. A copy of the record of the encounter that includes the patient's completed self-assessment. b. A written record of the contraceptive dispensed or dispensed and administered or the basis for not dispensing or dispensing and administering a contraceptive. c. Written information about the importance of seeing the patient's health-care practitioner to obtain recommended tests and screenings. (5) Dispense the contraceptive or dispense and administer the injectable hormonal contraceptive as soon as practicable after the pharmacist determines that the patient meets the requirements under the standing order.83 Del. Laws, c. 240, § 1;
16 DE Code § 3201. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3201. Short title.

§ 3201. Short title. This chapter may be cited as the “Delaware Cancer Control Act.” 62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;
16 DE Code § 3202. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3202. Purpose.

§ 3202. Purpose. The intent of the General Assembly is to require the establishment and maintenance of a cancer registry for the State. This responsibility is delegated to the Department of Health and Social Services, along with the authority to exercise certain powers to implement this requirement. To ensure an accurate and continuing source of data concerning cancer and certain specified tumors of a benign nature, the General Assembly by this chapter requires certain health care practitioners and all hospitals, clinical laboratories and cancer treatment centers within the State to make available to the Department of Health and Social Services information contained in the medical records of patients who have cancer or tumors of a benign nature. It is intended that the product of these efforts will be a central data bank of accurate, precise and current information regarding the subject diseases. 62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;
16 DE Code § 3203. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3203. Definitions.

§ 3203. Definitions. The following words, terms and phrases, when used in this chapter, shall have the meanings ascribed to them in this section, except where the context clearly indicates a different meaning. (1) “Benign tumor” means any nonmalignant neoplasm, regardless of the tissue of origin, that appears on the American College of Surgeons most recently published annual list of reportable cancers and benign tumors. (2) “Cancer” means any malignant neoplasm, regardless of the tissue of origin, that appears on the American College of Surgeons most recently published annual list of reportable cancers and benign tumors. (3) “Department” means the State of Delaware Department of Health and Social Services.62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;
16 DE Code § 3204. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3204. Cancer registry.

§ 3204. Cancer registry. The Department shall adopt, promulgate, amend and repeal any rules and regulations that are consistent with law relative to this chapter and necessary to achieve the purpose and requirements of this chapter. These rules and regulations shall include provisions for:  (1) The establishment and maintenance of an up-to-date registry that shall document every occurrence of cancer and of benign tumor in this State; (2) The establishment of a procedure for reporting to the Department, within 180 days of initial diagnosis or treatment, every occurrence of cancer and of benign tumor in this State. Such procedure shall include the reporting of specified information that the Department deems necessary and appropriate for the recognition, prevention, control or cure of cancer and benign tumors, and shall minimally include the reporting requirements of the National Cancer Data Base established by the American College of Surgeons, along with information regarding the patient's length of residency in Delaware, primary residential address in Delaware and the location and nature of the patient's primary past employment. Those required to report to the Department occurrences of cancer and benign tumors shall include:  a. Any physician, surgeon, dentist, podiatrist or other health-care practitioner who diagnoses or provides treatment for cancer or benign tumors; b. The designated representative of any hospital, dispensary, asylum or other similar public or private institution that diagnoses or provides treatment for cancer or benign tumors; and c. The designated representative of any laboratory that examines tissue specimens which disclose the existence of cancer or benign tumor; (3) The establishment of a procedure for the publication and distribution of forms, instructions and notices required by this chapter or necessary to accomplish the purpose of this chapter; and (4) The establishment of a procedure to obtain follow-up information from those required to report occurrences of cancer and benign tumors pursuant to this chapter. Any follow-up information deemed necessary by the Department shall be submitted to the Department at least 1 time each year by those required to report occurrences of cancer and benign tumors. This chapter and any rules or regulations issued pursuant to this chapter shall not apply to any person or private institution that, as an exercise of religious freedom, treats the sick or suffering by spiritual means through prayer alone. 62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;  73 Del. Laws, c. 431, §§  1, 2;
16 DE Code § 3205. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3205. Confidentiality of reports.

§ 3205. Confidentiality of reports. (a) Any report of an occurrence of cancer or benign tumor made pursuant to this chapter shall not be divulged nor made public in any way that might tend to disclose the identity of the person to whom it relates. However, patient-identifying information may be exchanged among cancer control agencies as authorized by the Department and upon receipt by the Department of satisfactory assurances by those agencies of the preservation of the confidentiality of such information. (b) No individual or organization providing information to the Department in accordance with this chapter shall be deemed to be, or held liable for, divulging confidential information. 62 Del. Laws, c. 334, §  1;  63 Del. Laws, c. 288, §  1;  70 Del. Laws, c. 149, §  148;  70 Del. Laws, c. 391, §  1;
16 DE Code § 3206. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3206. Compulsion prohibited.

§ 3206. Compulsion prohibited. Nothing in this chapter shall be construed to compel any individual to submit to any medical or public health examination, treatment or supervision. 62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;
16 DE Code § 3207. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3207. Violations.

§ 3207. Violations. Any person or entity who violates any provision of this chapter shall be fined $100 for each violation. 62 Del. Laws, c. 334, §  1;  70 Del. Laws, c. 391, §  1;  73 Del. Laws, c. 431, §  3;
16 DE Code § 3208. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 32. Cancer Control Act|§ 3208. Audit and Abstraction of records by department.

§ 3208. Audit and Abstraction of records by department. (a) Upon request of a person or organization required to report by § 3204 of this title, the Department may audit records and abstract information that is required to be reported. (b) Any person or organization failing to report as required by this chapter shall permit the Department to audit records and abstract information that is required to be reported. (c) The Department may charge a fee to be established by regulation to persons and organizations subjected to an audit pursuant to subsection (a) or (b) of this section. Said person or organization shall reimburse the Department. 73 Del. Laws, c. 431, §  3;
16 DE Code § 3301. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 33. Pure Food and Drugs|§ 3301. Definitions.

§ 3301. Definitions. As used in this chapter:  (1) “Drug” includes all medicines and preparations recognized in the United States Pharmacopoeia or National Formulary for internal or external use and any substance or mixture of substances intended to be used for the cure, mitigation or prevention of disease of either humans or other animals. Notwithstanding any other provision of this subdivision, the word “drug” shall not include laetrile (amygdalin). (2) “Food” includes all articles used for food, drink, ice, confectionery or condiment by humans or other animal, whether simple, mixed or compound.32 Del. Laws, c. 190, §  2;  Code 1935, §  3994;  16 Del. C. 1953, §  3301;  61 Del. Laws, c. 90, §  1;  66 Del. Laws, c. 314, §  1;  70 Del. Laws, c. 186, §  1;
16 DE Code § 3302. (2021)
2021 Delaware Code|Title 16 - Health and Safety|Chapter 33. Pure Food and Drugs|§ 3302. Manufacture or sale of adulterated or misbranded food or drugs.

§ 3302. Manufacture or sale of adulterated or misbranded food or drugs. No person shall manufacture, sell or trade in, within this State, any article of food or drugs which is adulterated, misbranded, poisonous or deleterious within the meaning of this chapter. 32 Del. Laws, c. 190, §  1;  Code 1935, §  3993;  16 Del. C. 1953, §  3302;